Cargando…

Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation

Primary carnitine deficiency (PCD) is a rare autosomal recessive disorder caused by loss of function mutations in the solute carrier family 22 member 5 (SLC22A5) gene that encodes a high-affinity sodium-ion–dependent organic cation transporter protein (OCTN2). Reduced carnitine transport results in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jakoby, Michael, Jaju, Amruta, Marsh, Aundrea, Wilber, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155745/ https://www.ncbi.nlm.nih.gov/pubmed/34032155 http://dx.doi.org/10.1177/23247096211019543

Ejemplares similares

Broadening the Spectrum of SLC22A5 Phenotype: Primary Carnitine Deficiency Presenting with Focal Myoclonus
por: Khries, Maymunah, et al.
Publicado: (2023)

Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018)

Identification of SLC22A5 Gene Mutation in a Family with Carnitine Uptake Defect
por: Mutlu-Albayrak, Hatice, et al.
Publicado: (2015)

A mutation creating an upstream translation initiation codon in SLC22A5 5′UTR is a frequent cause of primary carnitine deficiency
por: Ferdinandusse, Sacha, et al.
Publicado: (2019)

The determination of the effect(s) of solute carrier family 22-member 2 (SLC22A2) haplotype variants on drug binding via molecular dynamic simulation systems
por: Abrahams-October, Zainonesa, et al.
Publicado: (2022)

Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs
por: Lai, Raymond E., et al.
Publicado: (2018)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

Distribution, Molecular Structure and Functional Analysis of Carnitine Transporter (SLC22A5) in Canine Lens Epithelial Cells
por: OCHIAI, Hideharu, et al.
Publicado: (2014)

SLC22A5 (OCTN2) Carnitine Transporter—Indispensable for Cell Metabolism, a Jekyll and Hyde of Human Cancer
por: Juraszek, Barbara, et al.
Publicado: (2019)

An integrated bioinformatic investigation of mitochondrial solute carrier family 25 (SLC25) in colon cancer followed by preliminary validation of member 5 (SLC25A5) in tumorigenesis
por: Chen, Yan-Jie, et al.
Publicado: (2022)

PT604. Attenuation of PTZ-induced epileptic seizure by deficiency in the gene encoding solute carrier OCTN1/SLC22A4
por: Nakamichi, Noritaka, et al.
Publicado: (2016)

Neuroplastinβ-mediated upregulation of solute carrier family 22 member 18 antisense (SLC22A18AS) plays a crucial role in the epithelial-mesenchymal transition, leading to lung cancer cells' enhanced motility
por: Bajkowska, Karolina, et al.
Publicado: (2020)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma
por: Liu, Yidong, et al.
Publicado: (2015)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

Novel (sulfated) thyroid hormone transporters in the solute carrier 22 family
por: Chen, Zhongli, et al.
Publicado: (2023)

Welcome to the Family: Identification of the NAD(+) Transporter of Animal Mitochondria as Member of the Solute Carrier Family SLC25
por: Ziegler, Mathias, et al.
Publicado: (2021)

EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer
por: Nayak, Debasis, et al.
Publicado: (2022)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

The Mitochondrial Carnitine Acyl-carnitine Carrier (SLC25A20): Molecular Mechanisms of Transport, Role in Redox Sensing and Interaction with Drugs
por: Tonazzi, Annamaria, et al.
Publicado: (2021)

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018)

The Effect of Turmeric (Curcuma longa) Extract on the Functionality of the Solute Carrier Protein 22 A4 (SLC22A4) and Interleukin-10 (IL-10) Variants Associated with Inflammatory Bowel Disease
por: McCann, Mark J., et al.
Publicado: (2014)

Inhibition of the Mitochondrial Glutamate Carrier SLC25A22 in Astrocytes Leads to Intracellular Glutamate Accumulation
por: Goubert, Emmanuelle, et al.
Publicado: (2017)

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene
por: Zhou, Yunguo, et al.
Publicado: (2023)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

Unraveling the functional role of the orphan solute carrier, SLC22A24 in the transport of steroid conjugates through metabolomic and genome-wide association studies
por: Yee, Sook Wah, et al.
Publicado: (2019)

SLC22A5 polymorphism associated with risk of extra-articular manifestations in rheumatoid arthritis patients
por: Pawlik, Andrzej, et al.
Publicado: (2019)

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
por: Chen, Peixian, et al.
Publicado: (2022)

The human solute carrier family 11 member 1 protein (SLC11A1): linking infections, autoimmunity and cancer?
por: Awomoyi, Agnes A
Publicado: (2007)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of Solute Carrier Family 6 Member 8 (SLC6A8)
por: Yang, Xin, et al.
Publicado: (2022)

Role of SLC4 and SLC26 solute carriers during oxidative stress
por: Remigante, Alessia, et al.
Publicado: (2022)

The Molecular Effects of a Polymorphism in the 5′UTR of Solute Carrier Family 44, Member 5 that Is Associated with Birth Weight in Holsteins
por: Sugimoto, Mayumi, et al.
Publicado: (2012)

Correction: Vol. 22, No. 5
Publicado: (2016)

Multiple Endocrine Neoplasia Type 1 (MEN1) Presenting as an Invasive Macroprolactinoma Complicated by Acute Bacterial Meningitis
por: Bandaru, Sindhura, et al.
Publicado: (2021)

5,5′-Dimethyl-2,2′-bipyridine
por: Khoshtarkib, Zeinab, et al.
Publicado: (2009)

TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake
por: Osman, Islam, et al.
Publicado: (2019)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

New Insight on Solute Carrier Family 27 Member 6 (SLC27A6) in Tumoral and Non-Tumoral Breast Cells
por: Yen, Meng-Chi, et al.
Publicado: (2019)

Solute Carrier Family 37 Member 2 (SLC37A2) Negatively Regulates Murine Macrophage Inflammation by Controlling Glycolysis
por: Wang, Zhan, et al.
Publicado: (2020)

Human solute carrier SLC6A14 is the β-alanine carrier
por: Anderson, Catriona M H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_afgf8t1blklpvaej00a2hrbm75